Biopharma | search
Click here to view Biopharma news from 60+ newspapers.
Bookmark or Share- Rapid growth in biopharma: Challenges and opportunitiesToday, biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8 percent is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable ...
- Biopharmaceutical benchmarks 2022 | Nature BiotechnologyGary Walsh & Eithne Walsh. Nature Biotechnology 40 , 1722–1760 ( 2022) Cite this article. 28k Accesses. 95 Citations. 34 Altmetric. Metrics. Monoclonal antibodies as a group continue to lead...
- Biopharma dealmaking in 2023 - NatureThe biopharma industry went through a year of transition in 2023. Companies faced challenges, from difficult public financing markets, to venture capitalists who now, more than ever, are more...
- Fresh from the biotech pipeline: record-breaking FDA approvals87 Altmetric. Metrics. New drug approvals reached an all-time high in 2023, with five gene therapies, the first CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug. D3Damon / iStock...
- The biopharma industry outlook on 2024: Guarded optimism for a rebound ...By Ben Fidler • Jan. 11, 2024. Investors and executives interviewed by BioPharma Dive at J.P. Morgan say new companies have to be leaner, hire more conservatively and focus on their first medicines quickly. Read the full article . 10 clinical trials to watch in the first half of 2024.
More
